ImmunityBio, Inc. IBRX

I hope we get FDA approval for papillary after the close and many are caught out or light :)

I bought 10,000 more may buy another 10,000

We have a BCG shortage because Merck has a monopoly as the only manufacturer in America and they still grow it with potatoes.

BCG from India BCG from Japan is going to eliminate Merck's monopoly and way under price them into ending production. Next Anktiva will replace Keytruda for all of its uses. When Ketruda goes off patent 2028 US and 2030 no one else will make it. Why the market for it will be collapsing as Anktiva takes over.

Buy hold for the next 5 plus years and get rich.

Who is selling?
Why would anyone be selling?
Selling makes zero sense.

So sick of this. We should be on a nice positive feed back of share price rising.

Something is very off about how IBRX trades.

Robertm good advice be a long term investor Like an institutional investor not a penny flipping retail investor

Omarkingw try emailing MSM with attached articles and ask why they don't cover any news related to ImmunityBio

https://seekingalpha.com/article/4907099-immunitybio-one-approval-away-from-a-multi-billion-dollar-breakout

I had a Dream I woke up 2030 and the share price was $238

We would be at $50 plus if MSM would cover the ImmunityBio news

Send this email to MSM I have tried nice for a year pound them with emails

How can you ignore ImmunityBio day after day week after week month after month? I know no ad revenue it's greed and protecting your big pharma $$$$$$$......

Attach sever news link use these email addresses do it let them know thousands know about IBRX and the MSM silence

CNBCtipline@nbcuni.com

newstips@fox.com

news.tips@abc.com

customercare@cnbc.com

Wow and zero coverage from the no news corrupt MSM ????